| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Pharmacy Practice Act is amended by changing | |||||||||||||||||||
5 | Section 4 as follows:
| |||||||||||||||||||
6 | (225 ILCS 85/4) (from Ch. 111, par. 4124)
| |||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2018)
| |||||||||||||||||||
8 | Sec. 4. Exemptions. Nothing contained in any Section of | |||||||||||||||||||
9 | this Act shall
apply
to, or in any manner interfere with:
| |||||||||||||||||||
10 | (a) the lawful practice of any physician licensed to | |||||||||||||||||||
11 | practice medicine in
all of its branches, dentist, podiatric | |||||||||||||||||||
12 | physician,
veterinarian, or therapeutically or diagnostically | |||||||||||||||||||
13 | certified optometrist within
the limits of
his or her license, | |||||||||||||||||||
14 | or prevent him or her from
supplying to his
or her
bona fide | |||||||||||||||||||
15 | patients
such drugs, medicines, or poisons as may seem to him | |||||||||||||||||||
16 | appropriate;
| |||||||||||||||||||
17 | (b) the sale of compressed gases;
| |||||||||||||||||||
18 | (c) the sale of patent or proprietary medicines and | |||||||||||||||||||
19 | household remedies
when sold in original and unbroken packages | |||||||||||||||||||
20 | only, if such patent or
proprietary medicines and household | |||||||||||||||||||
21 | remedies be properly and adequately
labeled as to content and | |||||||||||||||||||
22 | usage and generally considered and accepted
as harmless and | |||||||||||||||||||
23 | nonpoisonous when used according to the directions
on the |
| |||||||
| |||||||
1 | label, and also do not contain opium or coca leaves, or any
| ||||||
2 | compound, salt or derivative thereof, or any drug which, | ||||||
3 | according
to the latest editions of the following authoritative | ||||||
4 | pharmaceutical
treatises and standards, namely, The United | ||||||
5 | States Pharmacopoeia/National
Formulary (USP/NF), the United | ||||||
6 | States Dispensatory, and the Accepted
Dental Remedies of the | ||||||
7 | Council of Dental Therapeutics of the American
Dental | ||||||
8 | Association or any or either of them, in use on the effective
| ||||||
9 | date of this Act, or according to the existing provisions of | ||||||
10 | the Federal
Food, Drug, and Cosmetic Act and Regulations of the | ||||||
11 | Department of Health
and Human Services, Food and Drug | ||||||
12 | Administration, promulgated thereunder
now in effect, is | ||||||
13 | designated, described or considered as a narcotic,
hypnotic, | ||||||
14 | habit forming, dangerous, or poisonous drug;
| ||||||
15 | (d) the sale of poultry and livestock remedies in original | ||||||
16 | and unbroken
packages only, labeled for poultry and livestock | ||||||
17 | medication;
| ||||||
18 | (e) the sale of poisonous substances or mixture of | ||||||
19 | poisonous substances,
in unbroken packages, for nonmedicinal | ||||||
20 | use in the arts or industries
or for insecticide purposes; | ||||||
21 | provided, they are properly and adequately
labeled as to | ||||||
22 | content and such nonmedicinal usage, in conformity
with the | ||||||
23 | provisions of all applicable federal, state and local laws
and | ||||||
24 | regulations promulgated thereunder now in effect relating | ||||||
25 | thereto
and governing the same, and those which are required | ||||||
26 | under such applicable
laws and regulations to be labeled with |
| |||||||
| |||||||
1 | the word "Poison", are also labeled
with the word "Poison" | ||||||
2 | printed
thereon in prominent type and the name of a readily | ||||||
3 | obtainable antidote
with directions for its administration;
| ||||||
4 | (f) the delegation of limited prescriptive authority by a | ||||||
5 | physician
licensed to
practice medicine in all its branches to | ||||||
6 | a physician assistant
under Section 7.5 of the Physician | ||||||
7 | Assistant Practice Act of 1987. This
delegated authority under | ||||||
8 | Section 7.5 of the Physician Assistant Practice Act of 1987 | ||||||
9 | may, but is not required to, include prescription of
controlled | ||||||
10 | substances, as defined in Article II of the
Illinois Controlled | ||||||
11 | Substances Act, in accordance with a written supervision | ||||||
12 | agreement; and
| ||||||
13 | (g) the delegation of prescriptive authority by a physician
| ||||||
14 | licensed to practice medicine in all its branches or a licensed | ||||||
15 | podiatric physician to an advanced practice
nurse in accordance | ||||||
16 | with a written collaborative
agreement under Sections 65-35 and | ||||||
17 | 65-40 of the Nurse Practice Act ; and .
| ||||||
18 | (h) the sale or distribution of dialysate, drugs, or | ||||||
19 | devices necessary to perform home renal dialysis for patients | ||||||
20 | with chronic kidney failure, provided that all of the following | ||||||
21 | conditions are met: | ||||||
22 | (1) the dialysate, drugs, or devices are approved or | ||||||
23 | cleared by the federal Food and Drug Administration, as | ||||||
24 | required by federal law; | ||||||
25 | (2) the dialysate, drugs, or devices are lawfully held | ||||||
26 | by a manufacturer or the manufacturer's agent, which is |
| |||||||
| |||||||
1 | properly registered with the Board as a manufacturer or | ||||||
2 | wholesaler; | ||||||
3 | (3) the dialysate, drugs, or devices are held by the | ||||||
4 | manufacturer or the manufacturer's agent and delivered to | ||||||
5 | the patient in the original, sealed packaging from the | ||||||
6 | manufacturing facility; | ||||||
7 | (4) the dialysate, drugs, or devices are delivered only | ||||||
8 | by the manufacturer or the manufacturer's agent and only | ||||||
9 | upon receipt of a physician's order; and | ||||||
10 | (5) the manufacturer or the manufacturer's agent | ||||||
11 | delivers the dialysate, drugs, or devices directly to: (i) | ||||||
12 | a patient with chronic kidney failure, or his or her | ||||||
13 | designee, for the patient's self-administration of the | ||||||
14 | dialysis therapy or (ii) a health care provider or | ||||||
15 | institution for administration or delivery of the dialysis | ||||||
16 | therapy to a patient with chronic kidney failure. | ||||||
17 | (Source: P.A. 98-214, eff. 8-9-13.)
| ||||||
18 | Section 99. Effective date. This Act takes effect upon | ||||||
19 | becoming law.
|